LY2835219相关论文
Effect of abemaciclib(LY2835219)on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexp
Multidrug resistance(MDR)is the major obstacle of the success in cancer chemotherapy.The overexpression of ATP-binding c......
研究发现,估计90%的人类肿瘤中存在着Cyclin D–CDK4/6–INK4–Rb通路的异常,这条通路的异常改变,加速了细胞周期G1期进程,使得肿......
背景:乳腺癌的发病率和死亡率居全球女性恶性肿瘤之首。近年来,虽然手术、放化疗、内分泌和靶向治疗在乳腺癌治疗中取得了较大进展......
